ArticlemBio2019
An Experimental Group A
Erratum issuedOpen access · goldAbstract read
In one paragraph
Article in mBio, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 52 papers.
0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
9.8field-weighted citation impact, top 2% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
52 citing papers in PubMed, 84 citations in OpenAlex.
- An emm-type specific qPCR to track bacterial load during experimental human Streptococcus pyogenes pharyngitis.BMC infectious diseases · 2021Trial
- A staged clinical development and evidence-generation framework for Group A Streptococcus vaccines.NPJ vaccines · 2026Review
- Carbon metabolism and niche adaptation inmSphere · 2026Review
- Rational selection of antigenic targets for Group A Streptococcus vaccine: updates, challenges and opportunities.NPJ vaccines · 2026Review
- Group A Streptococcal Virulence Factors and Vaccine Development-An Update.Microorganisms · 2026Review
- Revisiting the streptococcal M protein: modern perspectives on antibody function, host interactions, and therapeutic targeting.Frontiers in immunology · 2026Review
- The "Cairo Accord"- towards the eradication of RHD: revisited (2026).Frontiers in cardiovascular medicine · 2026Review
- Early-life serological profiles and the development of natural protective humoral immunity to Streptococcus pyogenes in a high-burden setting.Nature medicine · 2025Article
- Rhamnose polysaccharide-decorated outer membrane vesicles as a vaccine candidate targeting Group A Streptococcus fromVaccine: X · 2025Article
- Engaging Broader Stakeholders to Accelerate Group AVaccines · 2025Review
- The N-terminal ELRThe Journal of biological chemistry · 2025Article
- Article
- The burden of group AiScience · 2025Review
- A mini review of the pathogenesis of acute rheumatic fever and rheumatic heart disease.Frontiers in cellular and infection microbiology · 2025Review
- Streptococcus pyogenes pharyngitis elicits diverse antibody responses to key vaccine antigens influenced by the imprint of past infections.Nature communications · 2024Article
- The intricate pathogenicity of Group AVirulence · 2024Review
- Increasing Rate of FatalMicroorganisms · 2024Article
- Efficacy of Alum-Adjuvanted Peptide and Carbohydrate Conjugate Vaccine Candidates against Group AVaccines · 2024Article
- Development and characterization of a hemolysis inhibition assay to determine functionality of anti-Streptolysin O antibodies in human sera.Journal of immunological methods · 2024Article
- Immunomodulating Enzymes fromMicroorganisms · 2024Review
Corrections and comments
- Erratum issued
Authors and funding
13 authors at 6 institutions in 3 countries.
Tania Rivera-HernandezAustralian Infectious Diseases Research Centre, The University of Queensland, St Lucia, QLD, Australia.
Diane G CarnathanEmory Vaccine Center, Emory University, Atlanta, Georgia, USA.
Scott JonesGreat Ormond Street Institute of Child Health, University College London, London, United Kingdom.
Amanda J CorkAustralian Infectious Diseases Research Centre, The University of Queensland, St Lucia, QLD, Australia.
Mark R DaviesAustralian Infectious Diseases Research Centre, The University of Queensland, St Lucia, QLD, Australia.ORCID 0000-0001-6141-5179
Peter M MoyleAustralian Infectious Diseases Research Centre, The University of Queensland, St Lucia, QLD, Australia.
Istvan TothAustralian Infectious Diseases Research Centre, The University of Queensland, St Lucia, QLD, Australia.
Michael R BatzloffInstitute for Glycomics, Griffith University, Gold Coast, QLD, Australia.
James McCarthyAustralian Infectious Diseases Research Centre, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Victor NizetDivision of Host-Microbe Systems and Therapeutics, Department of Pediatrics, University of California-San Diego, La Jolla, California, USA.ORCID 0000-0003-3847-0422
David GoldblattGreat Ormond Street Institute of Child Health, University College London, London, United Kingdom.
Guido SilvestriEmory Vaccine Center, Emory University, Atlanta, Georgia, USA.
Mark J WalkerAustralian Infectious Diseases Research Centre, The University of Queensland, St Lucia, QLD, Australia mark.walker@uq.edu.au.
The University of Queensland · AUEmory University · USGreat Ormond Street Hospital · GBGriffith University · AUQIMR Berghofer Medical Research Institute · AUUniversity of California San Diego · US
Funding
Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0MGAS Switch from Colonizing Bacterium to Invasive PathogenR01AI077780 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI NIZET, VICTOR · 2008 to 2019
$3.8MNIAID NIH HHS R01 AI077780NIH HHS P51 OD011132
Abstract
Group A
Indexed as
AnimalsAntibodies, BacterialDisease Models, AnimalFemaleMacaca mulattaMalePharyngitisStreptococcal InfectionsStreptococcal VaccinesStreptococcus pyogenesTonsillitisTreatment OutcomeAntibodies, BacterialStreptococcal Vaccinesgroup A Streptococcusimmunizationnonhuman primatesStreptococcus pyogenes
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.